Greenwood Capital Associates’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,863
| Closed | -$347K | – | 227 |
|
|
2022
Q2 | $347K | Sell |
5,863
-2,169
| -27% | -$128K | 0.06% | 186 |
|
|
2022
Q1 | $934K | Buy |
8,032
+344
| +4% | +$40K | 0.25% | 85 |
|
|
2021
Q4 | $1.16M | Buy |
7,688
+37
| +0.5% | +$5.57K | 0.16% | 108 |
|
|
2021
Q3 | $913K | Buy |
7,651
+81
| +1% | +$9.67K | 0.14% | 118 |
|
|
2021
Q2 | $737K | Buy |
7,570
+87
| +1% | +$8.47K | 0.11% | 143 |
|
|
2021
Q1 | $660K | Buy |
7,483
+1,374
| +22% | +$121K | 0.1% | 153 |
|
|
2020
Q4 | $585K | Buy |
6,109
+647
| +12% | +$62K | 0.1% | 151 |
|
|
2020
Q3 | $620K | Sell |
5,462
-662
| -11% | -$75.1K | 0.12% | 111 |
|
|
2020
Q2 | $606K | Sell |
6,124
-1,329
| -18% | -$132K | 0.14% | 84 |
|
|
2020
Q1 | $480K | Sell |
7,453
-427
| -5% | -$27.5K | 0.14% | 78 |
|
|
2019
Q4 | $470K | Buy |
7,880
+2,341
| +42% | +$140K | 0.1% | 114 |
|
|
2019
Q3 | $327K | Buy |
+5,539
| New | +$327K | 0.08% | 121 |
|